237 related articles for article (PubMed ID: 27875502)
1. Sniffing Out Paediatric Gastrointestinal Diseases: The Potential of Volatile Organic Compounds as Biomarkers for Disease.
Buijck M; Berkhout DJ; de Groot EF; Benninga MA; van der Schee MP; Kneepkens CM; de Boer NK; de Meij TG
J Pediatr Gastroenterol Nutr; 2016 Dec; 63(6):585-591. PubMed ID: 27875502
[TBL] [Abstract][Full Text] [Related]
2. Volatile organic compounds as diagnostic biomarkers in gastrointestinal and liver diseases.
Probert CS; Ahmed I; Khalid T; Johnson E; Smith S; Ratcliffe N
J Gastrointestin Liver Dis; 2009 Sep; 18(3):337-43. PubMed ID: 19795029
[TBL] [Abstract][Full Text] [Related]
3. Differentiation Between Pediatric Irritable Bowel Syndrome and Inflammatory Bowel Disease Based on Fecal Scent: Proof of Principle Study.
Bosch S; van Gaal N; Zuurbier RP; Covington JA; Wicaksono AN; Biezeveld MH; Benninga MA; Mulder CJ; de Boer NKH; de Meij TGJ
Inflamm Bowel Dis; 2018 Oct; 24(11):2468-2475. PubMed ID: 29788410
[TBL] [Abstract][Full Text] [Related]
4. Volatile organic compounds in breath as markers for irritable bowel syndrome: a metabolomic approach.
Baranska A; Mujagic Z; Smolinska A; Dallinga JW; Jonkers DM; Tigchelaar EF; Dekens J; Zhernakova A; Ludwig T; Masclee AA; Wijmenga C; van Schooten FJ
Aliment Pharmacol Ther; 2016 Jul; 44(1):45-56. PubMed ID: 27136066
[TBL] [Abstract][Full Text] [Related]
5. Faecal volatile organic compounds analysis using field asymmetric ion mobility spectrometry: non-invasive diagnostics in paediatric inflammatory bowel disease.
van Gaal N; Lakenman R; Covington J; Savage R; de Groot E; Bomers M; Benninga M; Mulder C; de Boer N; de Meij T
J Breath Res; 2017 Nov; 12(1):016006. PubMed ID: 28439048
[TBL] [Abstract][Full Text] [Related]
6. Sniffing out causes of gastrointestinal disorders: a review of volatile metabolomic biomarkers.
Ahmed I; Niaz Z; Ewbank F; Akarca D; Felwick R; Furnari M
Biomark Med; 2018 Oct; 12(10):1139-1148. PubMed ID: 30191735
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive analysis of volatile biomarkers in human emanations for health and early disease diagnosis.
Kataoka H; Saito K; Kato H; Masuda K
Bioanalysis; 2013 Jun; 5(11):1443-59. PubMed ID: 23742311
[TBL] [Abstract][Full Text] [Related]
8. The scent of disease: volatile organic compounds of the human body related to disease and disorder.
Shirasu M; Touhara K
J Biochem; 2011 Sep; 150(3):257-66. PubMed ID: 21771869
[TBL] [Abstract][Full Text] [Related]
9. Detection of volatile organic compounds (VOCs) from exhaled breath as noninvasive methods for cancer diagnosis.
Sun X; Shao K; Wang T
Anal Bioanal Chem; 2016 Apr; 408(11):2759-80. PubMed ID: 26677028
[TBL] [Abstract][Full Text] [Related]
10. Volatile organic compounds as potential biomarkers of irritable bowel syndrome: A systematic review.
Zhang VR; Ramachandran GK; Loo EXL; Soh AYS; Yong WP; Siah KTH
Neurogastroenterol Motil; 2023 Jul; 35(7):e14536. PubMed ID: 36780514
[TBL] [Abstract][Full Text] [Related]
11. The analysis of volatile organic compounds in exhaled breath and biomarkers in exhaled breath condensate in children - clinical tools or scientific toys?
van Mastrigt E; de Jongste JC; Pijnenburg MW
Clin Exp Allergy; 2015 Jul; 45(7):1170-88. PubMed ID: 25394891
[TBL] [Abstract][Full Text] [Related]
12. Volatomics in inflammatory bowel disease and irritable bowel syndrome.
Van Malderen K; De Winter BY; De Man JG; De Schepper HU; Lamote K
EBioMedicine; 2020 Apr; 54():102725. PubMed ID: 32330874
[TBL] [Abstract][Full Text] [Related]
13. Diagnosing gastrointestinal illnesses using fecal headspace volatile organic compounds.
Chan DK; Leggett CL; Wang KK
World J Gastroenterol; 2016 Jan; 22(4):1639-49. PubMed ID: 26819529
[TBL] [Abstract][Full Text] [Related]
14. The Influence of Mechanical Bowel Preparation on Volatile Organic Compounds for the Detection of Gastrointestinal Disease-A Systematic Review.
Krishnamoorthy A; Chandrapalan S; Bosch S; Bannaga A; De Boer NKH; De Meij TGJ; Leja M; Hanna GB; De Vietro N; Altomare D; Arasaradnam RP
Sensors (Basel); 2023 Jan; 23(3):. PubMed ID: 36772415
[TBL] [Abstract][Full Text] [Related]
15. Non-invasive exhaled volatile organic biomarker analysis to detect inflammatory bowel disease (IBD).
Arasaradnam RP; McFarlane M; Daulton E; Skinner J; O'Connell N; Wurie S; Chambers S; Nwokolo C; Bardhan K; Savage R; Covington J
Dig Liver Dis; 2016 Feb; 48(2):148-53. PubMed ID: 26682719
[TBL] [Abstract][Full Text] [Related]
16. Volatile organic compounds at swine facilities: a critical review.
Ni JQ; Robarge WP; Xiao C; Heber AJ
Chemosphere; 2012 Oct; 89(7):769-88. PubMed ID: 22682363
[TBL] [Abstract][Full Text] [Related]
17. Extending landscape of volatile metabolites as novel diagnostic biomarkers of inflammatory bowel disease - a review.
Ahmed I; Fayyaz F; Nasir M; Niaz Z; Furnari M; Perry L
Scand J Gastroenterol; 2016; 51(4):385-92. PubMed ID: 26541790
[TBL] [Abstract][Full Text] [Related]
18. The versatile use of exhaled volatile organic compounds in human health and disease.
Boots AW; van Berkel JJ; Dallinga JW; Smolinska A; Wouters EF; van Schooten FJ
J Breath Res; 2012 Jun; 6(2):027108. PubMed ID: 22621865
[TBL] [Abstract][Full Text] [Related]
19. VOC breath biomarkers in lung cancer.
Saalberg Y; Wolff M
Clin Chim Acta; 2016 Aug; 459():5-9. PubMed ID: 27221203
[TBL] [Abstract][Full Text] [Related]
20. Targeted breath analysis: exogenous volatile organic compounds (EVOC) as metabolic pathway-specific probes.
Gaude E; Nakhleh MK; Patassini S; Boschmans J; Allsworth M; Boyle B; van der Schee MP
J Breath Res; 2019 May; 13(3):032001. PubMed ID: 30965287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
